Latest Breaking News On - காடிலா மருந்துகள் வரையறுக்கப்பட்டவை - Page 1 : comparemela.com

Altus Formulation Inc.: Cadila Pharmaceuticals and Altus Formulation Announce Successful Clinical Studies with TramaFlex Breakable Extended-Release Tablets tm Modified Release Technology Platform: New Safer to Use Value Added Tablets AHMEDABAD, INDIA and LAVAL, QC / ACCESSWIRE / January 27, 2021 / Cadila Pharmaceuticals Limited ( Cadila ) and Altus ) today announced the successful completion of human clinical studies with TramaFlex TM breakable extended-release (ER) tablets, a novel value-added once-daily formulation of tramadol hydrochloride for the improved treatment of patients with moderate to moderately severe pain. Developed by Altus using proprietary AmyloFlex TM technology, human bio-equivalence studies conducted by Cadila demonstrated TramaFlex ER tablets are bio-equivalent to 24hr ER products available commercially in North America, Europe, and Asia. Unlike marketed brands that can rapidly release their entire contents if damaged, with potentially life-threatenin

United statesM robert bechardKostenloser wertpapierhandelDamon smithCadila pharmaceuticals limitedCorporate developmentTechnology platformAltus formulation incCadila pharmaceuticals ltdCadila pharmaceuticalsSuccessful validationModified release technology platformNew saferUse value addedAltus formulationNorth america